Marina Mylnarsky
About Marina Mylnarsky
Marina Mylnarsky is the Director of R&ED Portfolio Management for Oncology, Heme, and CART at Bristol Myers Squibb, overseeing a significant budget and leading various financial and operational initiatives.
Director, R&ED Portfolio Management at Bristol Myers Squibb
Marina Mylnarsky serves as the Director, R&ED Portfolio Management: Oncology, Heme, CART at Bristol Myers Squibb. In this role, she oversees an annual budget of approximately $0.4 billion dedicated to Oncology/Hematology and CART development teams. She is instrumental in integrating hCelg and hBMS portfolios with a focus on transparency in study costing and simplifying processes. Additionally, she manages financial support for governance bodies including the R&ED Operations Committee, ED-OC, and Triage.
Financial Governance at Bristol Myers Squibb
Marina Mylnarsky plays a crucial role in financial governance at Bristol Myers Squibb. She provides financial support for multiple governance bodies such as the R&ED Operations Committee, ED-OC, and Triage. Her responsibilities include ensuring streamlined financial processes and maintaining transparency in budgeting and expenditure. Marina is also responsible for leading the implementation of standardized tools like the Oncology/Hematology and CART Biomarker Tool, enhancing the efficiency and accuracy of financial reporting.
Experience in Finance and Portfolio Management
Marina Mylnarsky's extensive experience in finance and portfolio management spans over several years within Bristol Myers Squibb. Previously, she held the titles of Associate Director, Portfolio Management (2017-2019), US Pharmaceuticals Finance Manager, Virology (2014-2016), US Pharmaceuticals Finance Manager, Reporting and Analysis (2010-2013), and Manager, Internal Controls, US Pharmaceuticals Finance (2007-2010). This breadth of experience has equipped her with deep knowledge in financial oversight and strategic portfolio management.
Implementation of Financial Systems and Tools
At Bristol Myers Squibb, Marina Mylnarsky has led significant initiatives to improve financial systems and tools. She co-led the implementation of the Anaplan system to utilize patient accrual data for R&D reporting and projected spend. In addition, she spearheaded the PLAYBOOK implementation, which focuses on integrated cross-functional processes. Her efforts have been key in making financial reporting more accurate and efficient, aligning internal processes with organizational goals.
Educational Background in Accounting
Marina Mylnarsky holds a Bachelor's Degree in Accounting from Rutgers, The State University of New Jersey-Newark. She completed her degree program from 1998 to 2002, laying a strong foundation for her career in finance and portfolio management. Her academic background in accounting has been pivotal in her various roles requiring deep financial acumen and strategic oversight.